- Home
- TOPS vs LGVN Comparison
TOPS vs LGVN Comparison
Compare TOPS & LGVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TOPS
- LGVN
- Stock Information
- Founded
- TOPS 2000
- LGVN 2014
- Country
- TOPS Greece
- LGVN United States
- Employees
- TOPS N/A
- LGVN N/A
- Industry
- TOPS Marine Transportation
- LGVN Medicinal Chemicals and Botanical Products
- Sector
- TOPS Consumer Discretionary
- LGVN Health Care
- Exchange
- TOPS Nasdaq
- LGVN Nasdaq
- Market Cap
- TOPS 27.6M
- LGVN 23.4M
- IPO Year
- TOPS 2004
- LGVN 2021
- Fundamental
- Price
- TOPS $5.30
- LGVN $1.35
- Analyst Decision
- TOPS
- LGVN Strong Buy
- Analyst Count
- TOPS 0
- LGVN 3
- Target Price
- TOPS N/A
- LGVN $8.67
- AVG Volume (30 Days)
- TOPS 6.6K
- LGVN 126.2K
- Earning Date
- TOPS 06-03-2025
- LGVN 05-08-2025
- Dividend Yield
- TOPS N/A
- LGVN N/A
- EPS Growth
- TOPS N/A
- LGVN N/A
- EPS
- TOPS 1.09
- LGVN N/A
- Revenue
- TOPS $86,127,000.00
- LGVN $2,225,000.00
- Revenue This Year
- TOPS $9.90
- LGVN N/A
- Revenue Next Year
- TOPS N/A
- LGVN $17.49
- P/E Ratio
- TOPS $4.87
- LGVN N/A
- Revenue Growth
- TOPS 3.83
- LGVN 127.50
- 52 Week Low
- TOPS $5.12
- LGVN $0.77
- 52 Week High
- TOPS $14.24
- LGVN $6.40
- Technical
- Relative Strength Index (RSI)
- TOPS 33.93
- LGVN 42.56
- Support Level
- TOPS $5.11
- LGVN $1.29
- Resistance Level
- TOPS $5.97
- LGVN $1.38
- Average True Range (ATR)
- TOPS 0.20
- LGVN 0.10
- MACD
- TOPS -0.05
- LGVN -0.01
- Stochastic Oscillator
- TOPS 20.87
- LGVN 30.00
About TOPS TOP Ships Inc.
TOP Ships Inc owns tanker vessels throughout the world. The Company is an international owner and operator of modern, fuel-efficient eco tanker vessels focusing on the transportation of crude oil, petroleum products (clean and dirty), and bulk liquid chemicals. It generates revenue from the Time Charter agreements.
About LGVN Longeveron Inc.
Longeveron Inc is a clinical-stage biotechnology company developing regenerative medicines to address unmet medical needs for specific aging-related and life-threatening conditions. Its investigational product is Lomecel-B an stem cell formulation sourced from the bone marrow of young, healthy adult donors and has potential mechanisms of action that can promote tissue repair and healing. The company currently has three pipeline indications: Hypoplastic Left Heart Syndrome (HLHS), Alzheimer's disease (AD) and Aging-related Frailty.